InvestorsHub Logo
Followers 88
Posts 1770
Boards Moderated 0
Alias Born 09/03/2009

Re: Mikesc post# 33360

Monday, 11/09/2015 12:15:00 PM

Monday, November 09, 2015 12:15:00 PM

Post# of 461833
This quote from Dr. Missling in this morning's press release really stood out to me along with a number of other great quotes:

“While we remain focused on Alzheimer’s, the remarkably fast onset of clinical effect of ANAVEX 2-73 increases our options to potentially pursue additional indications for diseases characterized by working memory impairment and may enable clinical trials to be completed within shorter time frames.” [emphasis added]

Could this be hinting at a fast track designation for Parkinsons, Epilepsy, Alzheimers, or?

Millstone
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News